跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RXR agonist
首页
药物
RXR agonist
RXR agonist
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
TREATMENT OF NERVOUS SYSTEM DISORDERS USING COMBINATIONS OF RXR AGONISTS AND THYROID HORMONES
EP 3368080 B8
申请人: IO THERAPEUTICS INC
优先权: 2015
CN
EP
US
WO
41 件公开
AUTOIMMUNE DISORDER TREATMENT USING RXR AGONISTS
EP 2790698 A1
申请人: IO THERAPEUTICS INC
优先权: 2011
CN
EP
US
23 件公开
TREATMENT OF CANCER WITH SPECIFIC RXR AGONISTS
EP 1937244 B1
申请人: IO THERAPEUTICS LLC
优先权: 2005
CN
EP
US
WO
16 件公开
TREATMENT OF AUTOIMMUNE DISEASES WITH COMBINATIONS OF RXR AGONISTS AND THYROID HORMONES
EP 4166160 A1
申请人: IO THERAPEUTICS INC
优先权: 2016
CN
EP
US
13 件公开
RXR AGONIST SALT FORMS, POLYMORPHS THEREOF, AND USES THEREOF
EP 4493536 A4
申请人: IO THERAPEUTICS INC
优先权: 2022
CN
EP
US
WO
7 件公开
COMBINATION THERAPY FOR HEAD AND NECK CANCER
EP 3116318 B1
申请人: UNIV CORNELL
优先权: 2014
CN
EP
US
6 件公开
TREATMENT OF MUSCULAR DISORDERS WITH COMBINATIONS OF RXR AGONISTS AND THYROID HORMONES
EP 3426303 B1
申请人: IO THERAPEUTICS INC
优先权: 2016
CN
EP
US
5 件公开
USE OF AN RXR AGONIST AND TAXANES IN TREATING HER2+ CANCERS
EP 4444287 A4
申请人: IO THERAPEUTICS INC
优先权: 2021
EP
US
WO
4 件公开
Compositions comprising a retinoid X receptor (RXR) agonist, a retinoic acid receptor (RAR) agonist, or a dual RXR/RAR agonist
US 12540121 B2
申请人: UNIV ARIZONA STATE
优先权: 2019
US
WO
4 件公开
COMPOSITIONS AND METHODS FOR TREATING NF1 AND OTHER CONDITIONS
EP 4611904 A4
申请人: UNIV MICHIGAN STATE
优先权: 2022
EP
US
WO
3 件公开
第 1 / 5 页
上一页
下一页
药物
反馈